Jupiter Neurosciences- Warrants(19/11/2026)'s net income is $-9.2M, below the sector sector average of $90M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
The latest net income for JUNSW is $-9.2M as of June 2026. That compares with $-5.9M in the prior-year period — down 55.9% year over year. That is below the sector sector average of $90M. Investors often review this figure alongside Jupiter Neurosciences- Warrants(19/11/2026)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, JUNSW's net income moved from $-5.9M to $-9.2M — a 55.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Jupiter Neurosciences- Warrants(19/11/2026)'s operating scale or balance-sheet position.
Against its sector companies, JUNSW currently prints $-9.2M for net income, while the sector average sits near $90M. That is roughly 110.2% below the sector mean. Large gaps often invite a closer look at Jupiter Neurosciences- Warrants(19/11/2026)'s growth, margins, and balance sheet.
A net income figure of $-9.2M for JUNSW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $90M. Explore the charts below for those layers of context.
After noting JUNSW's net income ($-9.2M), review year-over-year change from $-5.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.